On June 16, 2025 Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), reported that it will host an in-person and virtual R&D Day in New York on Thursday, June 26, 2025, from 9:00 AM to 12:00 PM ET (Press release, Crinetics Pharmaceuticals, JUN 16, 2025, View Source [SID1234653915]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event will provide an update including data on Crinetics’ early-stage pipeline assets, next steps, and portfolio strategy to drive long-term value. Key topics will include:

NETs and beyond – NDC platform with CRN09682
Graves’ disease and thyroid eye disease (TED) – TSH antagonist
Autosomal polycystic kidney disease (ADPKD) – SST3 agonist
A live question-and-answer session will follow the formal presentations.